Real-time enrollment status for this warm autoimmune hemolytic anemia (waiha) clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 11:51 AM UTC
| NCT Number | NCT07549698 |
| Recruiting Status | Recruiting |
| Condition | Warm Autoimmune Hemolytic Anemia (WAIHA) |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | CRISPR Therapeutics AG |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 30, 2026: Clinical trial NCT07549698 is currently recruiting participants. This phase1 study for warm autoimmune hemolytic anemia (waiha) is actively seeking new participants at 2 locations across the United States. The study is sponsored by CRISPR Therapeutics AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07549698 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07549698 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.